Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.

Abraham, Jonathan

Abraham, Jonathan.

Abraham J; From Harvard Medical School and Brigham and Women's Hospital, Boston.

N Engl J Med ; 386(23): 2236-2238, 2022 06 09.

Article in English | MEDLINE | ID: covidwho-1890346

Subject(s)

Antibodies, Monoclonal; Antineoplastic Agents, Immunological; COVID-19; Antibodies, Monoclonal/pharmacology; Antibodies, Monoclonal/therapeutic use; Antibodies, Neutralizing; Antineoplastic Agents, Immunological/pharmacology; Antineoplastic Agents, Immunological/therapeutic use; COVID-19/prevention & control; Half-Life; Humans; Immunoglobulin G

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / COVID-19 / Antibodies, Monoclonal Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google